What does CUSIP Y95308105 represent in this 13F holders report?

CUSIP Y95308105 is the security identifier for WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value used to aggregate holder disclosures.

How many institutions held WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in Q3 2017?

58 institutional investors reported WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value for Q3 2017. Use the holders table for investor-level position and value details.

Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class: Equity / Ordinary Shares, no par value
Shares outstanding: 188,679,245
Total 13F shares: 20,492,602
Share change: +1,176,369
Total reported value: $445,796,252
Price per share: $21.75
Number of holders: 58
Value change: +$26,521,810
Number of buys: 32
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2017
Previous quarter: Q2 2017

Recent filing periods for CUSIP Y95308105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.8%	7,088,651	$131,849,000	—	30 Jun 2017	13F
Redmile Group, LLC	13F	Company	1.2%	2,224,407	$41,374,000	—	30 Jun 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.93%	1,756,031	$32,662,000	—	30 Jun 2017	13F
FMR LLC	13F	Company	0.86%	1,629,049	$30,300,000	—	30 Jun 2017	13F
Foresite Capital Management III, LLC	13F	Company	0.53%	1,004,100	$18,676,000	—	30 Jun 2017	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.4%	746,841	$13,891,000	—	30 Jun 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.35%	662,798	$12,328,000	—	30 Jun 2017	13F
New Leaf Venture Partners, L.L.C.	13F	Company	0.35%	658,259	$12,244,000	—	30 Jun 2017	13F
BlackRock Finance, Inc.	13F	Company	0.29%	547,827	$10,189,000	—	30 Jun 2017	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.23%	433,500	$8,063,000	—	30 Jun 2017	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.19%	355,835	$6,619,000	—	30 Jun 2017	13F
VANGUARD GROUP INC	13F	Company	0.11%	215,691	$4,012,000	—	30 Jun 2017	13F
Cormorant Asset Management, LP	13F	Company	0.11%	202,079	$3,759,000	—	30 Jun 2017	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.1%	192,903	$3,588,000	—	30 Jun 2017	13F
NORTHERN TRUST CORP	13F	Company	0.09%	165,794	$3,085,000	—	30 Jun 2017	13F
STATE STREET CORP	13F	Company	0.08%	151,241	$2,815,000	—	30 Jun 2017	13F
SABBY MANAGEMENT, LLC	13F	Company	0.08%	141,700	$2,636,000	—	30 Jun 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	132,984	$2,473,000	—	30 Jun 2017	13F
Opaleye Management Inc.	13F	Company	0.07%	125,000	$2,325,000	—	30 Jun 2017	13F
Alyeska Investment Group, L.P.	13F	Company	0.05%	98,801	$1,838,000	—	30 Jun 2017	13F
JENNISON ASSOCIATES LLC	13F	Company	0.04%	75,435	$1,403,000	—	30 Jun 2017	13F
EMORY UNIVERSITY	13F	Company	0.04%	74,020	$1,377,000	—	30 Jun 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	72,189	$1,343,000	—	30 Jun 2017	13F
Marshall Wace North America L.P.	13F	Company	0.03%	61,286	$1,164,000	—	30 Jun 2017	13F
Iguana Healthcare Management, LLC	13F	Company	0.03%	55,000	$1,023,000	—	30 Jun 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	53,212	$990,000	—	30 Jun 2017	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.03%	49,000	$911,000	—	30 Jun 2017	13F
Bank of New York Mellon Corp	13F	Company	0.02%	47,104	$876,000	—	30 Jun 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	32,491	$604,000	—	30 Jun 2017	13F
Matisse Capital	13F	Company	0.01%	26,824	$499,000	—	30 Jun 2017	13F
WEXFORD CAPITAL LP	13F	Company	0.01%	25,000	$465,000	—	30 Jun 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	21,534	$401,000	—	30 Jun 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	21,009	$391,000	—	30 Jun 2017	13F
Swiss National Bank	13F	Company	0.01%	18,400	$342,000	—	30 Jun 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.01%	16,731	$311,000	—	30 Jun 2017	13F
MORGAN STANLEY	13F	Company	0.01%	14,439	$268,000	—	30 Jun 2017	13F
Vident Investment Advisory, LLC	13F	Company	0.01%	14,057	$261,000	—	30 Jun 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	13,835	$256,000	—	30 Jun 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	12,700	$236,000	—	30 Jun 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	12,700	$236,000	—	30 Jun 2017	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	12,502	$233,000	—	30 Jun 2017	13F
STRS OHIO	13F	Company	0.01%	11,900	$221,000	—	30 Jun 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	9,422	$175,000	—	30 Jun 2017	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	7,370	$137,000	—	30 Jun 2017	13F
Nationwide Fund Advisors	13F	Company	0%	6,720	$125,000	—	30 Jun 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	6,651	$124,000	—	30 Jun 2017	13F
Legal & General Group Plc	13F	Company	0%	3,151	$60,000	—	30 Jun 2017	13F
UBS Group AG	13F	Company	0%	3,000	$56,000	—	30 Jun 2017	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1,284	$23,882	—	30 Jun 2017	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	1,043	$19,000	—	30 Jun 2017	13F

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q3 2017

As of 30 Sep 2017, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,492,602 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Foresite Capital Management III, LLC, New Leaf Venture Partners, L.L.C., PERCEPTIVE ADVISORS LLC, Point72 Asset Management, L.P., BlackRock Inc., and DEERFIELD MANAGEMENT CO. This page lists 58 institutional shareholders reporting positions in this security for the Q3 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders

Q3 2017 holders

Holder diff

Investor	Q2 2017 Shares	Q3 2017 Shares	Share Diff	Share Chg %	Q2 2017 Value $	Q3 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.